The clinical information you need, at your fingertips.

Hovilpri approved as first-in-class treatment for refractory HSV

ADHD may leave a cognitive mark decades later

NAD booster misses the mark in early Parkinson's disease

Broader pneumococcal vaccine meets phase 3 immune-response goals

FDA approves Tecentriq, first adjuvant immunotherapy for stage III dMMR colon cancer

Resmetirom or semaglutide for MASH? New guidance helps clinicians choose

Vaping at home tied to worse asthma control in kids

Can AI identify reliable home BP monitors? New study raises concerns

Bed-sharing with dogs not tied to worse sleep